Key result
In-person outpatient visits linked to ~58% lower mortality in heart failure.
Why the study?
The mortality risk associated with loss of in-person outpatient visits or transition to virtual care in patients with HF during the COVID-19 pandemic was unknown.
Cohort (n=509,511)
Yes
Observed mortality link with visits should not change practice; leaves open causality versus confounding in retrospective data.
BACKGROUND: The mortality risk associated with loss of in-person outpatient visits or transition to virtual care in patients with heart failure (HF) during the COVID-19 pandemic is unknown. OBJECTIVES: Assess changes in outpatient HF care patterns and associated mortality. METHODS: Retrospective analysis of HF patients using national Veterans-Health-Administration (VHA) data. Among 509,511 HF patients who received VHA care, we compared mean monthly days-with-an-outpatient-visit from 2/2018-1/2020 (pre-COVID) versus 2/2020-1/2021 (COVID) using T-tests. In a subset of 321,439 patients with ≥1 VHA cardiology or primary-care visit in 2019, we related the presence and type of outpatient visit with mortality using Cox-Regression estimated hazard-ratios (HRs). RESULTS: Despite a 2-3-fold increase in video-only visits and use of telephone visits to maintain access, the overall days with outpatient visits decreased from a monthly-average of 81.4 ± 6.1 in 2018-2019 and 81.0 ± 5.6 in 2019-2020, to 57.8 ± 11 days in 2020-2021 (P < 0.01 for both), per 100 Veterans. When compared to patients with no-visits during the study period, the adjusted-mortality risk was lowest for patients with at least one in-person (HR 0.42, 95%CI: 0.41-0.44), followed by video-only (HR 0.52, 95%CI: 0.50-0.55) and then telephone-only (HR 0.57, 95%CI: 0.54-0.60) visits (p = 0.14 for trend). Results remained similar when the analysis was repeated (without including telephone visits) for pre-COVID (2/2018-1/2020) periods. CONCLUSIONS: Despite an increase in video and use of telephone visits during the COVID-19 pandemic, there was still a decrease in total outpatient visits for patients with HF. The presence and type of outpatient encounter was associated with the adjusted risk of mortality.
No takes yet. Share an insight, caveat, or question.
Vijayakumar et al. (2025) conducted a cohort in Heart failure (n=509,511). In-person outpatient visits vs. No visits was evaluated on Mortality (HR 0.42, 95% CI 0.41-0.44). Among Veterans with heart failure, having at least one in-person outpatient visit was associated with a lower mortality risk compared to no visits (HR 0.42; 95% CI 0.41-0.44).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: